Summary
Patients with erythema migrans can fail to respond to antibiotic therapy. Persistent or recurrent erythema migrans, major sequelae such as meningitis and arthritis, survival ofBorrelia burgdorferi and significant and persistent increase of antibody titres againstB. burgdorferi after antibiotic therapy are strong indications of a treatment failure. Most, if not all, antibiotics used so far have been associated with a treatment failure in patients with erythema migrans. Roxithromycin and erythromycin are definitely or probably ineffective. However, doxycycline, amoxicillin, cefuroxime, ceftriaxone, azithromycin and high-dose penicillin V perform comparably well.
Zusammenfassung
Therapieversager können bei der antibiotischen Behandlung von Patienten mit Erythema migrans vorkommen. Hinweise für ein Versagen der Therapie liefern die Persistenz und das Rezidiv des Erythema migrans, das Auftreten von schwereren Spätfolgen wie Meningitis und Arthritis, die Persistenz vonBorrelia burgdorferi und eine signifikante und persistierende Erhöhung der Antikörpertiter gegenüberB. burgdorferi. Die meisten, wenn nicht alle bisher verwendeten Antibiotika ließen sich in einen Zusammenhang mit dem Therapieversagen beim Erythema migrans bringen. Roxithromycin und Erythromycin sind definitiv oder wahrscheinlich unwirksam. Doxycyclin, Amoxicillin, Azithromycin und hochdosiertes Penicillin V sind hingegen als vergleichsweise gut wirksame Antibiotika anzusehen.
Similar content being viewed by others
References
Hollström, E. Successful treatment of erythema migrans Afzelius. Acta Derm. Venereol. (Stockholm) 31 (1951) 235–243.
Weber, K. Erythema-chronicum-migrans-Meningitis — eine bakterielle Infektionskrankheit? Münch. Med. Wochenschr. 116 (1974) 1993–1998.
Steere, A. C., Hutchinson, G. J., Rahn, D. W., Sigal, L. H., Craft, J. E., De Senna, E. T., Malawista, S. E. Treatment of early manifestations of Lyme disease. Ann. Intern. Med. 99 (1983) 22–26.
Weber, K., Neubert, U., Büchner, S. A. Erythema migrans and early signs and symptoms. In:Weber, K., Burgdorfer, W. (eds.): Aspects of Lyme borreliosis. Springer, Berlin 1993, pp. 105–121.
Hollström, E. Penicillin treatment of erythema chronicum migrans Afzelius. Acta Derm. Venereol. (Stockholm) 38 (1958) 285–289.
Hansen, K., Hovmark, A., Lebech, A. M., Lebech, K., Olsson, I., Halkier-Sörensen, L., Olsson, E., Asbrink, E. Roxithromycin in Lyme borreliosis: discrepant results of anin vitro andin vivo animal susceptibility study and a clinical trial in patients with erythema migrans. Acta Derm. Venereol. (Stockholm) 72 (1992) 297–300.
Weber, K., Preac-Mursic, V., Wilske, B., Thurmayr, R., Neubert, U., Scherwitz, C. A randomized trial of ceftriaxone versus oral penicillin for the treatment of early European Lyme borreliosis. Infection 18 (1990) 91–96.
Weber, K., Neubert, U., Thurmayr, R. Antibiotic therapy in early erythema migrans disease and related disorders. Zentralbl. Bakteriol. Hyg. (A) 263 (1986) 377–388.
Weber, K., Wilske, B., Preac-Mursic, V., Thurmayr, R. Azithromycin versus penicillin V for the treatment of early Lyme borreliosis. Infection 21 (1993) 367–372.
Weber, K., Pfister, H. W. Clinical management of Lyme borreliosis. Lancet i (1994) 1017–1020.
Preac-Mursic, V., Weber, K., Pfister, H. W., Wilske, B., Gross, B., Baumann, A., Prokop, J. Survival ofBorrelia burgdorferi in antibiotically treated patients with Lyme borreliosis. Infection 17 (1989) 355–359.
Massarotti, E. M., Luger, S. W., Rahn, D. W., Messner, R. P., Wong, J. B., Johnson, R. C., Steere, A. C. Treatment of early Lyme disease. Am. J. Med. 92 (1992) 396–403.
Wienecke, R., Zöchling, N., Neubert, U., Schlüpen, E. M., Meurer, M., Volkenandt, M. Molecular subtyping ofBorrelia burgdorferi in erythema migrans and acrodermatitis chronica atrophicans. J. Invest. Dermatol. 103 (1994) 19–22.
von Stedingk, L. V., Olsson, I., Hanson, H. S., Asbrink, E., Hovmark, A. Polymerase chain reaction for detection ofBorrelia burgdorferi DNA in skin lesions of early and late Lyme borreliosis. Eur. J. Clin. Microbiol. Infect. Dis. 14 (1995) 1–5.
Weber, K., Preac-Mursic, V., Neubert, U., Thurmayr, R., Herzer, P., Wilske, B., Schierz, G., Marget, W. Antibiotic therapy of early European Lyme borreliosis and acrodermatitis chronica atrophicans. Ann. NY Acad. Sci 539 (1988) 324–345.
Wilske, B., Schierz, G., Preac-Mursic, V., Weber, K., Pfister, H. W., Einhäupl, K. M. Serological diagnosis of erythema migrans disease and related disorders. Infection 12 (1984) 331–337.
Strle, F., Ruzic, E., Cimpermann, J. Erythema migrans: comparison of treatment with azithromycin, doxycycline and phenoxymethylpenicillin. J. Antimicrob. Chemother. 30 (1992) 543–550.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Weber, K. Treatment failure in erythema migrans — a review. Infection 24, 73–75 (1996). https://doi.org/10.1007/BF01780663
Issue Date:
DOI: https://doi.org/10.1007/BF01780663